openPR Logo
Press release

Global Human Recombinant Insulin Market – Industry Insights

09-06-2018 03:09 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Human Recombinant Insulin Market – Industry Insights

Discovery of insulin is considered to be one of the most important events in the history of the diabetes treatment. Furthermore, major advances in human insulin technology is the synthesis of human insulin analogue by recombinant technology. Currently, human insulin delivery system available for the administration of insulin include insulin syringes, insulin pumps, jet injections, and pens. Key players are focused on developing recombinant human insulin instead of animal-based insulin, owing to increasing demand for human insulin in the treatment of diabetes. Human recombinant insulin has a faster onset of action and lower immunogenicity than pork or beef insulin. Currently human recombinant insulin is gaining significant traction with the development of biosimilar analogue of human insulin.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1797

According to the Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS): 2016 report, the insulin market including human recombinant insulin largely contributes around 40 local manufacturers, with largely local markets apart from three largest global insulin manufactures: Novo Nordisk A/S, Sanofi S.A. and Eli Lilly and Company. Furthermore, various manufacturers offer a recombinant analog of human insulin-like growth factor that has been specifically engineered for the research and industrial cell culture market, providing a consistent, compliant, and reliable alternative to recombinant insulin. Such manufacturers include: Merck KGaA, Thermo Fisher Scientific, Inc., among others. These manufacturers offers recombinant human insulin analogue products as a raw material or blended with custom media formulations for small scale process development and commercial biomanufacturing applications. Launch of biosimilar and other insulin products and research for recombinant insulin products is expected to drive growth of the market during the forecast period.

Moreover, rising diabetes population, worldwide combined with increasing research and development (R&D) activities by various government and private organizations in human insulin development is expected to boost growth of the human recombinant insulin market in the near future.

The global human recombinant insulin market was valued at US$ 27.4 billion in 2018, and is expected to witness a CAGR of 7.2% over the forecast period (2018 – 2026).

Click To Reading More On
https://www.coherentmarketinsights.com/market-insight/human-recombinant-insulin-market-1797

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Human Recombinant Insulin Market – Industry Insights here

News-ID: 1224881 • Views: 210

More Releases from Coherent Market Insights

Explosive Detection Technologies Market Is Expected to Witness CAGR of 7.0% Duri …
Explosive detection technologies refer to a system or equipment that is used for destructive identification of explosive materials. Explosive detection is commonly used at ports, airports, and border control. There are two types of explosive detection equipment namely trace detection and bulk detection. Different technologies are used in explosive X-ray, infrared, biosensors, optical, non-optical, etc. Several types of machines are used to detect trace signatures of explosive materials, in which
Dust Control System Market Is Expected To Witness CAGR Of 4.3% During The Foreca …
A dust collection or dust control system is an air quality enhancement system that is used in commercial, industrial, and domestic applications to improve air quality of the surrounding and remove particulate matter from the environment. Such devices are either manually or remotely controlled. Dust control systems are segregated into two types of filters, which are defined below. Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3307 Dry Type Dust Control System This system consists of
Personalized Gene Therapy Treatments for Cancer Market: 2020 What Recent Study S …
Gene therapy involves insertion of genetic material into cells of the patients to provide them a new function or to restore the missing or inappropriate functioning of the cells due to cancer or gene mutations. Scientists have created personalized medicines that are used to learn about a person's genetic makeup and untangle the biologic nature of the patient's cancerous cells for carrying out such therapies. This Personalized Gene Therapy Treatments for
Barcode Verifiers Market: Industry Size and Share Evolution to 2027 by Growth In …
Barcode verifiers are electronic devices used to measure the quality of a 1D, 2D, and Direct Part Mark (DPM) codes. Barcode verifier reads the barcode and performs a series of tests to examine the scan ability and quality of the barcode in comparison to the industry specification and standards. Any trade partner in the supply chain can use the barcode verifier to test the quality of the barcode. Get Sample Copy

All 5 Releases


More Releases for Human

Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
metamorphis the Human Story
contact: Rosalyn Lifshin, Executive Director Ocean City Arts Center, rozl@oceancityartscenter.orgCo (609) 399-7628
Human Resources or Human Capital?
Are people really an organisation's most important asset? Not necessarily. Some are liabilities – but some undoubtedly are the most important drivers of value that an organisation has. The question is – who are they? How do we know? How can we maximise the value they have and the value they provide? These questions are what human capital management is about. This book explains the answers and discusses approaches